|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
EP0377676B1
(en)
|
1987-09-17 |
1995-05-24 |
Massachusetts Institute Of Technology |
Human erythroid-specific transcriptional enhancer
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
WO1992001070A1
(en)
|
1990-07-09 |
1992-01-23 |
The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce |
High efficiency packaging of mutant adeno-associated virus using amber suppressions
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
JP3534749B2
(ja)
|
1991-08-20 |
2004-06-07 |
アメリカ合衆国 |
アデノウイルスが介在する胃腸管への遺伝子の輸送
|
|
US5436150A
(en)
|
1992-04-03 |
1995-07-25 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
|
|
US5356802A
(en)
|
1992-04-03 |
1994-10-18 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease
|
|
US5487994A
(en)
|
1992-04-03 |
1996-01-30 |
The Johns Hopkins University |
Insertion and deletion mutants of FokI restriction endonuclease
|
|
DE69434860T2
(de)
|
1993-02-22 |
2007-03-15 |
The Rockefeller University |
Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
FR2712812B1
(fr)
|
1993-11-23 |
1996-02-09 |
Centre Nat Rech Scient |
Composition pour la production de produits thérapeutiques in vivo.
|
|
CA2187626C
(en)
|
1994-04-13 |
2009-11-03 |
Michael G. Kaplitt |
Aav-mediated delivery of dna to cells of the nervous system
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US6004797A
(en)
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
|
US6027721A
(en)
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
|
US6136597A
(en)
|
1997-09-18 |
2000-10-24 |
The Salk Institute For Biological Studies |
RNA export element
|
|
US20020065236A1
(en)
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
|
ATE351916T1
(de)
|
1999-10-12 |
2007-02-15 |
Pasteur Institut |
Lentivirale triplex-dns, und vektoren und rekombinante zellen, die lentivirale triplex-dns enthalten
|
|
CA2406743A1
(en)
|
2000-04-28 |
2001-11-08 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
|
|
US6627442B1
(en)
|
2000-08-31 |
2003-09-30 |
Virxsys Corporation |
Methods for stable transduction of cells with hiv-derived viral vectors
|
|
GB0024550D0
(https=)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
|
EP1412493B1
(en)
|
2001-08-02 |
2011-10-05 |
Institut Clayton De La Recherche |
Methods and compositions relating to improved lentiviral vector production systems
|
|
EP1438075A4
(en)
|
2001-10-02 |
2006-04-19 |
Inst Clayton De La Rech |
METHOD AND COMPOSITIONS ASSOCIATED WITH LENTIVIRAL VECTORS WITH LIMITED EXPRESSION AND ITS APPLICATIONS
|
|
NZ532635A
(en)
|
2001-11-13 |
2007-05-31 |
Univ Pennsylvania |
A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
|
|
NZ536899A
(en)
*
|
2002-05-02 |
2008-04-30 |
Univ Rochester |
Vectors having both isoforms of beta-hexosaminidase
|
|
AU2003274397A1
(en)
|
2002-06-05 |
2003-12-22 |
University Of Florida |
Production of pseudotyped recombinant aav virions
|
|
EP1529105B1
(en)
|
2002-08-12 |
2012-10-03 |
Société de commercialisation des produits de la recherche appliquée SOCPRA Sciences Santé et Humaines s.e.c. |
Methods to reprogram splice site selection in pre-messenger rnas
|
|
WO2004094642A2
(en)
|
2003-04-24 |
2004-11-04 |
Fondazione Centro San Raffaele Del Monte Tabor |
Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
CN1856576B
(zh)
|
2003-09-30 |
2011-05-04 |
宾夕法尼亚州立大学托管会 |
腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
|
|
US20060171935A1
(en)
|
2005-01-31 |
2006-08-03 |
Asa Abeliovich |
Protecting cell therapy for neurological disorders including Parkinson's disease
|
|
JP2007054069A
(ja)
|
2005-08-24 |
2007-03-08 |
Medizinische Hochschule Hannover |
自己不活性化レトロウイルスベクター
|
|
US7867484B2
(en)
|
2006-01-27 |
2011-01-11 |
University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
EP2152889B1
(en)
|
2007-05-29 |
2017-03-15 |
Nature Technology Corporation |
Vectors and methods for genetic immunization
|
|
WO2009012176A2
(en)
|
2007-07-14 |
2009-01-22 |
The University Of Iowa Research Foundation |
Methods and compositions for treating brain diseases
|
|
WO2009026116A2
(en)
|
2007-08-16 |
2009-02-26 |
Genizon Biosciences, Inc. |
Genemap of the human genes associated with longevity
|
|
AU2010241864B2
(en)
|
2009-04-30 |
2014-02-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
DE102009021592A1
(de)
|
2009-05-15 |
2010-11-18 |
Medizinische Hochschule Hannover |
ASLV-Vektorsystem
|
|
WO2011053825A2
(en)
|
2009-10-30 |
2011-05-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for the treatment or prevention of mitochondrial diseases
|
|
JP2013523776A
(ja)
|
2010-04-02 |
2013-06-17 |
セレジーン インコーポレイテッド |
パーキンソン病および脳のドーパミン作動性ニューロンのその他の障害を処置する方法
|
|
US8603994B2
(en)
|
2010-11-11 |
2013-12-10 |
Valted, Llc |
Transcriptional repression leading to Parkinson's disease
|
|
US9434928B2
(en)
|
2011-11-23 |
2016-09-06 |
Nationwide Children's Hospital, Inc. |
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
|
|
AU2013221212B2
(en)
|
2012-02-17 |
2018-08-09 |
The Children's Hospital Of Philadelphia |
AAV vector compositions and methods for gene transfer to cells, organs and tissues
|
|
AU2013243948A1
(en)
*
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
EP2669381A1
(en)
|
2012-05-30 |
2013-12-04 |
AmVac AG |
Method for expression of heterologous proteins using a recombinant negative-strand RNA virus vector comprising a mutated P protein
|
|
KR102530118B1
(ko)
|
2012-07-25 |
2023-05-08 |
더 브로드 인스티튜트, 인코퍼레이티드 |
유도 ｄｎａ 결합 단백질 및 게놈 교란 도구 및 이의 적용
|
|
EP2792742A1
(en)
|
2013-04-17 |
2014-10-22 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
Gene-therapy vectors for treating cardiomyopathy
|
|
US9585971B2
(en)
|
2013-09-13 |
2017-03-07 |
California Institute Of Technology |
Recombinant AAV capsid protein
|
|
GB201318347D0
(en)
|
2013-10-16 |
2013-11-27 |
Ucl Business Plc |
Retroviral vectors
|
|
CN120174012A
(zh)
*
|
2013-10-24 |
2025-06-20 |
优尼科Ip有限公司 |
用于基因治疗神经疾病的aav-5假型载体
|
|
EP3760719A1
(en)
|
2013-11-18 |
2021-01-06 |
CRISPR Therapeutics AG |
Crispr-cas system materials and methods
|
|
CA2945335A1
(en)
|
2014-04-18 |
2015-10-22 |
Editas Medicine, Inc. |
Crispr-cas-related methods, compositions and components for cancer immunotherapy
|
|
CN107405411A
(zh)
|
2014-05-01 |
2017-11-28 |
华盛顿大学 |
使用腺病毒载体的体内基因改造
|
|
IL248102B
(en)
|
2014-05-02 |
2022-07-01 |
Genzyme Corp |
aav vectors for gene therapy of the central nervous system and retina
|
|
US11030531B2
(en)
|
2014-06-06 |
2021-06-08 |
Trustees Of Boston University |
DNA recombinase circuits for logical control of gene expression
|
|
US10781459B2
(en)
|
2014-06-20 |
2020-09-22 |
University Of Florida Research Foundation, Incorporated |
Methods of packaging multiple adeno-associated virus vectors
|
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
|
US10350245B2
(en)
|
2015-01-21 |
2019-07-16 |
Fred Hutchinson Cancer Research Center |
Point-of-care and/or portable platform for gene therapy
|
|
CN107635575A
(zh)
|
2015-03-10 |
2018-01-26 |
纽约市哥伦比亚大学理事会 |
重组glut1腺相关病毒载体构建体以及用于恢复glut1表达的相关方法
|
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
|
US20170029798A1
(en)
|
2015-07-27 |
2017-02-02 |
Cellivery Therapeutics, Inc. |
Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)
|
|
WO2017083750A1
(en)
|
2015-11-11 |
2017-05-18 |
Intrexon Corporation |
Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
|
|
KR102423442B1
(ko)
|
2015-12-11 |
2022-07-20 |
캘리포니아 인스티튜트 오브 테크놀로지 |
아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드
|
|
DK3405215T3
(da)
|
2016-01-19 |
2022-09-19 |
Univ California |
Fremgangsmåder til behandling af danon-sygdom og andre autofagilidelser
|
|
WO2017136536A1
(en)
|
2016-02-02 |
2017-08-10 |
University Of Massachusetts |
Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
|
|
CA3021572A1
(en)
|
2016-04-20 |
2017-10-26 |
Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas |
Compositions and methods for enhanced gene expression of pklr
|
|
US11260081B2
(en)
*
|
2016-06-29 |
2022-03-01 |
Ramot At Tel-Aviv University Ltd. |
Engineered parasites for delivering protein to the central nervous system (CNS)
|
|
CN110536966A
(zh)
|
2016-09-08 |
2019-12-03 |
能源环境和技术研究中心O.A.,M.P. |
用于范可尼贫血患者的基因疗法
|
|
JP7059285B2
(ja)
|
2016-09-30 |
2022-04-25 |
エステベ プアルマセウティカルス， エッセ．ア． |
ムコ多糖症の治療のためのアデノ随伴ウイルスベクター
|
|
US20180326022A1
(en)
|
2017-04-21 |
2018-11-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for improving heart function and treating heart failure
|
|
US20200199534A1
(en)
|
2017-04-27 |
2020-06-25 |
Fred Hutchinson Cancer Research Center |
Therapeutic formulations containing cd34+ stem cells derived from negative selection
|
|
EP3697452A4
(en)
|
2017-10-16 |
2021-11-24 |
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P. |
LENTIVIRAL VECTORS FOR ADMINISTRATION OF PKLR TO TREAT PYRUVATE KINASE DEFECTS
|
|
BR112020020841A2
(pt)
|
2018-04-11 |
2021-01-19 |
Fundacion Para La Investigacion Biomedica Del Hospital Infantil Universitario Nino Jesus |
Composições e métodos para transplante de célulastronco
|
|
CA3096293A1
(en)
|
2018-04-27 |
2019-10-31 |
Rocket Pharmaceuticals, Ltd. |
Gene therapy for cns degeneration
|
|
AU2019258830B2
(en)
|
2018-04-27 |
2025-12-18 |
Universität Heidelberg |
Modified AAV capsid polypeptides for treatment of muscular diseases
|
|
WO2020014523A1
(en)
|
2018-07-12 |
2020-01-16 |
Rocket Pharmaceuticals, Ltd. |
Gene therapy vectors for treatment of danon disease
|
|
KR20210046004A
(ko)
|
2018-07-30 |
2021-04-27 |
센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. |
조혈 세포의 유전자 변형 방법
|
|
EP3833745A1
(en)
|
2018-08-10 |
2021-06-16 |
REGENXBIO Inc. |
Scalable method for recombinant aav production
|
|
JP2021533831A
(ja)
|
2018-08-16 |
2021-12-09 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
ウイルスベクターのための生成方法
|
|
AU2020221842A1
(en)
|
2019-02-12 |
2021-08-12 |
Spacecraft Seven, Llc |
Gene therapy vectors for treatment of Danon Disease
|
|
CN113994008A
(zh)
|
2019-05-23 |
2022-01-28 |
太空飞船七有限责任公司 |
用于婴儿恶性骨硬化病的基因治疗载体
|
|
IL297391A
(en)
|
2020-04-20 |
2022-12-01 |
Tenaya Therapeutics Inc |
An adeno-associated virus with an engineered capsid
|
|
JP2023535121A
(ja)
|
2020-05-20 |
2023-08-16 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
操作されたパーキン及びその使用
|
|
JP2023526449A
(ja)
|
2020-05-21 |
2023-06-21 |
ニスノバイオ ジーティー，エルエルシー |
パーキンソン病を治療するための、増加した活性を有するパーキン変異体の遺伝子治療送達
|
|
WO2022017630A1
(en)
|
2020-07-23 |
2022-01-27 |
Ucl Business Ltd |
GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF
|
|
BR112023001336A2
(pt)
|
2020-08-05 |
2023-02-14 |
Spacecraft Seven Llc |
Terapia gênica de csrp3 (proteína 3 rica em cisteína e glicina)
|
|
AU2021321412A1
(en)
|
2020-08-05 |
2023-04-06 |
Spacecraft Seven, Llc |
Adeno-associated viral vector for GLUT1 expression and uses thereof
|
|
JP2023538519A
(ja)
|
2020-08-07 |
2023-09-08 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
Ａａｖベクターを使用したプラコフィリン－２（ｐｋｐ２）遺伝子治療
|
|
CA3201247A1
(en)
|
2020-12-07 |
2022-06-16 |
Gaurav Shah |
Treatment of danon disease
|
|
US20250135040A1
(en)
|
2022-02-08 |
2025-05-01 |
Spacecraft Seven, Llc |
Adeno-associated viral vector for glut1 expression and uses thereof
|